32.44
Roundhill Glp 1 Weight Loss Etf Borsa (OZEM) Ultime notizie
Novo Nordisk A/S (NVO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Roundhill Glp-1 & Weight Loss ETF (OZEM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Eli Lilly and Co (LLY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
OZEM Dividend: 1.27% Yield, $0.41/Share — History & Dates - GuruFocus
OZEM ETF Profile: Dividends, Returns (BOATS:OZEM) - TradingView
OZEM ETF Profile: Dividends, Returns (NASDAQ:OZEM) - TradingView
OZEM ETF Profile: Dividends, Returns (CFI:OZEM) - TradingView
OZEM Archives - 24/7 Wall St.
Weight Loss ETFs Poised to Rally as Medicare Greenlights GLP-1 Coverage - The Globe and Mail
5 Best GLP-1 Stocks for 2026 and How to Invest - The Motley Fool
3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend - The Globe and Mail
Rhythm Pharmaceuticals Inc (RYTM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Scholar Rock Holding Corp (SRRK) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Biohaven Ltd (BHVN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Metsera Inc (MTSR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Viking Therapeutics Inc (VKTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Structure Therapeutics Inc (GPCR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
AstraZeneca PLC (AZN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Terns Pharmaceuticals Inc (TERN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Pfizer Inc (PFE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Healthcare ETFs: From Broad Exposure to Big Breakthroughs - ETF Trends
Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market - The Globe and Mail
TD Cowen Raises GLP-1 Sales Forecast To $150B By 2030 – Industry Leaders LLY, NVO To Remain Dominant - TradingView
GLP-1 Drug Giants Race to Go Global With Their Obesity Pills: ETFs to Gain - The Globe and Mail
485BPOS: Post-effective amendment - Moomoo
3 Ways to Invest in the Growing GLP-1 Weight Loss Market - MarketBeat
Stock List: Research Stocks from Around the World - GuruFocus
USA Stocks: Research Stocks from USA Stock Market - GuruFocus
OZEM Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
OZEM Stock Price, News & Analysis - Stock Titan
Can You Buy Ozempic Stock in 2026? - The Motley Fool
FDA Approves NVO's Increased Wegovy Dosage: Broaden Your Portfolio With These Healthcare ETFs - Bitget
FDA Clears NVO's Higher Dose of Wegovy: Diversify With These Health ETFs - The Globe and Mail
Discipline and Rules-Based Execution in OZEM Response - Stock Traders Daily
Here are the quant ratings of OZEM’s top holdings amid Novo's selloff - MSN
OZEM stock: What the Ratings say (OZEM:NASDAQ) - Seeking Alpha
ETFs with Pfizer Inc. ( PFE ) Exposure - ETF Database
Behavioral Patterns of OZEM and Institutional Flows - Stock Traders Daily
Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) Short Interest Up 47.1% in January - Defense World
(OZEM) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Healthcare ETFs to Watch as Novo Nordisk Tumbles on Poor Sales Outlook - The Globe and Mail
NVO Receives FDA Approval for MASH Therapy: ETFs Expected to Benefit - intellectia.ai
OZEM Vs. THNR: Which Is The Better ETF In The GLP-1 And Weight Loss Space? - Seeking Alpha
EXCLUSIVE: Trump 'Amplified' Several Investing Themes – ETF CEO Picks 3 Sectors Benefitting The Most - Benzinga
Capitalizzazione:
|
Volume (24 ore):